These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19656633)

  • 21. Antibiotic and hemolytic activity of a beta2/beta3 peptide capable of folding into a 12/10-helical secondary structure.
    Arvidsson PI; Ryder NS; Weiss HM; Gross G; Kretz O; Woessner R; Seebach D
    Chembiochem; 2003 Dec; 4(12):1345-7. PubMed ID: 14661278
    [No Abstract]   [Full Text] [Related]  

  • 22. Membrane-active Antimicrobial Peptides as Template Structures for Novel Antibiotic Agents.
    Lohner K
    Curr Top Med Chem; 2017; 17(5):508-519. PubMed ID: 28117020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects.
    Palm C; Netzereab S; Hällbrink M
    Peptides; 2006 Jul; 27(7):1710-6. PubMed ID: 16500001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria.
    Lambert PA
    J Appl Microbiol; 2002; 92 Suppl():46S-54S. PubMed ID: 12000612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of faropenem compared with eight agents against fourteen Gram-positive and Gram-negative bacteria by time-kill.
    Credito KL; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2003 Jun; 51(6):1437-9. PubMed ID: 12746376
    [No Abstract]   [Full Text] [Related]  

  • 27. [Phage lytic enzymes--new hope in battle against bacterial infections].
    Niczyporuk JS; Bartoszcze M
    Przegl Epidemiol; 2007; 61(4):713-21. PubMed ID: 18572503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens.
    Gomarasca M; F C Martins T; Greune L; Hardwidge PR; Schmidt MA; Rüter C
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage Lytic Enzymes.
    Briers Y
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30699900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunities for broadening the application of cell wall lytic enzymes.
    Bhagwat A; Mixon M; Collins CH; Dordick JS
    Appl Microbiol Biotechnol; 2020 Nov; 104(21):9019-9040. PubMed ID: 32945900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From bacterial killing to immune modulation: Recent insights into the functions of lysozyme.
    Ragland SA; Criss AK
    PLoS Pathog; 2017 Sep; 13(9):e1006512. PubMed ID: 28934357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic insights and therapeutic opportunities of antimicrobial chemokines.
    Crawford MA; Margulieux KR; Singh A; Nakamoto RK; Hughes MA
    Semin Cell Dev Biol; 2019 Apr; 88():119-128. PubMed ID: 29432954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lytic peptidase L5 of Lysobacter sp. XL1 with broad antimicrobial spectrum.
    Vasilyeva NV; Shishkova NA; Marinin LI; Ledova LA; Tsfasman IM; Muranova TA; Stepnaya OA; Kulaev IS
    J Mol Microbiol Biotechnol; 2014; 24(1):59-66. PubMed ID: 24434599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial Agents Targeting the Bacterial Cell Wall.
    Shan L; Wenling Q; Mauro P; Stefano B
    Curr Med Chem; 2020; 27(17):2902-2926. PubMed ID: 32003656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outer membrane vesicles of Lysobacter sp. XL1: biogenesis, functions, and applied prospects.
    Kudryakova IV; Shishkova NA; Vasilyeva NV
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):4791-801. PubMed ID: 27098257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translocation of non-lytic antimicrobial peptides and bacteria penetrating peptides across the inner membrane of the bacterial envelope.
    Frimodt-Møller J; Campion C; Nielsen PE; Løbner-Olesen A
    Curr Genet; 2022 Feb; 68(1):83-90. PubMed ID: 34750687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An AIEgen as an Intrinsic Antibacterial Agent for Light-Up Detection and Inactivation of Intracellular Gram-Positive Bacteria.
    Dai T; Guo B; Qi G; Xu S; Zhou C; Bazan GC; Liu B
    Adv Healthc Mater; 2021 Dec; 10(24):e2100885. PubMed ID: 34369089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portable plasma medical device for infection treatment.
    Thiyagarajan M; Waldbeser L
    Stud Health Technol Inform; 2012; 173():518-20. PubMed ID: 22357048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying enzymatic lysis: estimating the combined effects of chemistry, physiology and physics.
    Mitchell GJ; Nelson DC; Weitz JS
    Phys Biol; 2010 Oct; 7(4):046002. PubMed ID: 20921589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting what phage have evolved to control gram-positive pathogens.
    Fischetti VA
    Bacteriophage; 2011 Jul; 1(4):188-194. PubMed ID: 23050211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.